Newborn Screening for CAH—Challenges and Opportunities

Abstract

Abstract
Newborn screening for congenital adrenal hyperplasia (CAH) using 17-hydroxyprogesterone (17-OHP) as an indicator of disease was first introduced in the 1970s [...] Full article
(This article belongs to the Special Issue CAH Screening—Challenges and Opportunities)
11 pages, 457 KiB
Open AccessArticle